MAPK3 and acute lymphoblastic leukemia: In multiple B-ALL cell lines, we found that αGAL-9 antibody treatment increased AKT and ERK1 gene expression levels more dramatically in leukemia cells cultured in ACM relative to unconditioned medium (Supplementary Fig. 11c–e).